Scientific Advisory Board

The World Trade Group Scientific Advisory Board is a group of recognized experts and practionners from the life science industry.

The board meets a few times a year, either as a group or on a one-to-one basis to help drive the programmes to ensure it reflects the key industry concerns.

The board continually help review and mould our conference programmes, drawing upon their wealth of experience to advise on current industry developments and potential speakers, with many taking part in the event themselves.

Current Advisory Board Members Include:

	Dr. Lee Babiss Head of Global Pharma Research, Hoffmann-La Roche, Ltd, Switzerland
	Dr. David De Graaf Director of Systems Biology Pfizer Research Technology Center (RTC)USA
	Dr. Fadel Hamed Head of Operational Excellence Genentech Product Operations, USA
	Dr. Neil Weir Senior Vice President, Global Research, UCB Celltech UK
	Dr. Orest Hurko Assistant Vice President for Clinical Discovery, Translational Research Wyeth USA
	Prof. Ian Wilson Senior Principal Scientist AstraZeneca UK
	Robert Repetto Director Global New Technology and Innovation, Manufacturing Sciences & Technology, Wyeth Biotech, & Head of Disposables Technologies Task Force, Parenteral Drug Association – PDA USA
	Dr. Jinghai J. Xu Director of Automated Biotechnology Merck & Co USA

Application for membership

We are continually seeking new members to join our advisory boards. If you would like more information or would like to help drive the conference programme by becoming an Advisory Board member, please contact:

Dora Walsh
dora.walsh@wtgevents.com
Senior Analyst, Life Science Division,
World Trade Group
T: +44 (0) 20 7202 7695

Please note acceptance onto the advisory board is not automatic and each enquiry will be judged on its own merit. The Advisory Board reserves the right to reject applications based on incomplete or unverifiable information.